Farrell; Francis
Patent Applications and Registrations
Patent applications and USPTO patent grants for Farrell; Francis.The latest application filed is for "methods and compositions for treating fibrosis related disorders using il-17 antagonists".
- Farrell; Francis - Radnor PA
- Farrell; Francis - Doylestown PA
- Farrell, Francis - Buckingham PA
- Farrell; Francis - Madison NJ
| Patent | Date |
|---|---|
| Methods and Compositions for Treating Fibrosis Related Disorders Using IL-17 Antagonists App 20110091378 - Dudas; Paul ; et al. | 2011-04-21 |
| Resistin Antagonists And Their Use App 20110071277 - Blake; Simon ; et al. | 2011-03-24 |
| Compositions And Methods For Regulating Collagen And Smooth Muscle Actin Expression By Serpine2 App 20100183620 - BHAWE; KAUMUDI ; et al. | 2010-07-22 |
| Neuroprotective Peptides App 20090170759 - Smith-Swintosky; Virginia ; et al. | 2009-07-02 |
| Resistin Antagonists And Their Use App 20090162375 - Blake; Simon ; et al. | 2009-06-25 |
| Resistin Antagonists and Their Use App 20090117122 - Carton; Jill ; et al. | 2009-05-07 |
| Neuroprotective peptides Grant 7,259,146 - Smith-Swintosky , et al. August 21, 2 | 2007-08-21 |
| Erythropoietin dosing regimen for treating anemia Grant 7,232,797 - Farrell , et al. June 19, 2 | 2007-06-19 |
| Protein tyrosine phosphatase 1B (PTP-1B) inhibitors and methods of using the same App 20050159442 - Xu, Danlin ; et al. | 2005-07-21 |
| Use of erythropoietin in stroke recovery App 20040209812 - Renzi, Michael J. ; et al. | 2004-10-21 |
| Erythropoietin dosing regimen for treating anemia App 20030134795 - Farrell, Francis | 2003-07-17 |
| Neuroprotective peptides App 20030130197 - Smith-Swintosky, Virginia ; et al. | 2003-07-10 |
| Anti-tumor chemotherapy by administration of cyclophosphamide and erythropoeitin App 20030083250 - Farrell, Francis ; et al. | 2003-05-01 |
| Process for preparing instant beverage cubes Grant 4,031,238 - Reid , et al. June 21, 1 | 1977-06-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 